Targeting human γδ t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
- Author
- DIELI, Francesco1 ; VERMIJLEN, David2 ; SALERNO, Alfredo1 ; EBERL, Matthias4 5 ; HAYDAY, Adrian C2 ; FULFARO, Fabio3 ; CACCAMO, Nadia1 ; MERAVIGLIA, Serena1 ; CICERO, Giuseppe1 3 ; ROBERTS, Andrew2 ; BUCCHERI, Simona1 ; D'ASARO, Matilde1 ; GEBBIA, Nicola3
[1] Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, Palermo, Italy
[2] Peter Gorer Department of Immunobiology, The Medical School of King's College at Guy's and St. Thomas' Hospitals, London, United Kingdom
[3] Section of Medical Oncology, Dipartimento di Chirurgia ed Oncologia, Università di Palermo, Palermo, Italy
[4] Institute of Cell Biology, University of Bern, Bern, Switzerland
[5] Department of Medical Biochemistry and Immunology, Cardiff University School of Medicine, Cardiff, United Kingdom - Source
Cancer research (Baltimore). 2007, Vol 67, Num 15, pp 7450-7457, 8 p ; ref : 47 ref
- CODEN
- CNREA8
- ISSN
- 0008-5472
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Acide zolédronique Anticancéreux Cancer prostate Ciblage Cible Homme Immunothérapie Interleukine 2 Lymphocyte T Récepteur cellule T γ/δ Résistance traitement Traitement hormonal Antiostéoporotique Antirésorptif Appareil génital mâle pathologie Appareil urinaire pathologie Bisphosphonates Cytokine Diphosphonique acide dérivé Prostate pathologie Tumeur maligne
- Keyword (en)
- Zoledronic acid Antineoplastic agent Prostate cancer Targeting Target Human Immunotherapy Interleukin 2 T-Lymphocyte γ/δ T cell receptor Treatment resistance Hormone therapy Male genital diseases Urinary system disease Bisphosphonates Cytokine Diphosphonic acid derivatives Prostate disease Malignant tumor
- Keyword (es)
- Acido zoledrónico Anticanceroso Cáncer de la próstata Blancado Blanco Hombre Inmunoterapia Interleuquina 2 Linfocito T Receptor célula T γ/δ Resistencia tratamiento Hormonoterapia Aparato genital macho patología Aparato urinario patología Bisfosfonatos Citoquina Difosfonico ácido derivado Prostata patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D02 Urinary tract. Prostate gland
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20B Male genital diseases / 002B20B02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Nephrology. Urinary tract diseases Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19011670
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1158/0008-5472.CAN-07-0199 
https://dx.doi.org/10.1158/0008-5472.CAN-07-0199
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-07-0199\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"7450\";s:8:\"\u0000*\u0000epage\";s:4:\"7457\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DIELI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Francesco\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"VERMIJLEN, David\";i:1;s:16:\"SALERNO, Alfredo\";i:2;s:15:\"EBERL, Matthias\";i:3;s:16:\"HAYDAY, Adrian C\";i:4;s:14:\"FULFARO, Fabio\";i:5;s:14:\"CACCAMO, Nadia\";i:6;s:18:\"MERAVIGLIA, Serena\";i:7;s:16:\"CICERO, Giuseppe\";i:8;s:15:\"ROBERTS, Andrew\";i:9;s:16:\"BUCCHERI, Simona\";i:10;s:16:\"D'ASARO, Matilde\";i:11;s:14:\"GEBBIA, Nicola\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-07-0199\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"7450\";s:8:\"\u0000*\u0000epage\";s:4:\"7457\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DIELI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Francesco\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"VERMIJLEN, David\";i:1;s:16:\"SALERNO, Alfredo\";i:2;s:15:\"EBERL, Matthias\";i:3;s:16:\"HAYDAY, Adrian C\";i:4;s:14:\"FULFARO, Fabio\";i:5;s:14:\"CACCAMO, Nadia\";i:6;s:18:\"MERAVIGLIA, Serena\";i:7;s:16:\"CICERO, Giuseppe\";i:8;s:15:\"ROBERTS, Andrew\";i:9;s:16:\"BUCCHERI, Simona\";i:10;s:16:\"D'ASARO, Matilde\";i:11;s:14:\"GEBBIA, Nicola\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-07-0199\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-07-0199\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"7450\";s:8:\"\u0000*\u0000epage\";s:4:\"7457\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DIELI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Francesco\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"VERMIJLEN, David\";i:1;s:16:\"SALERNO, Alfredo\";i:2;s:15:\"EBERL, Matthias\";i:3;s:16:\"HAYDAY, Adrian C\";i:4;s:14:\"FULFARO, Fabio\";i:5;s:14:\"CACCAMO, Nadia\";i:6;s:18:\"MERAVIGLIA, Serena\";i:7;s:16:\"CICERO, Giuseppe\";i:8;s:15:\"ROBERTS, Andrew\";i:9;s:16:\"BUCCHERI, Simona\";i:10;s:16:\"D'ASARO, Matilde\";i:11;s:14:\"GEBBIA, Nicola\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-07-0199\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"7450\";s:8:\"\u0000*\u0000epage\";s:4:\"7457\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DIELI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Francesco\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"VERMIJLEN, David\";i:1;s:16:\"SALERNO, Alfredo\";i:2;s:15:\"EBERL, Matthias\";i:3;s:16:\"HAYDAY, Adrian C\";i:4;s:14:\"FULFARO, Fabio\";i:5;s:14:\"CACCAMO, Nadia\";i:6;s:18:\"MERAVIGLIA, Serena\";i:7;s:16:\"CICERO, Giuseppe\";i:8;s:15:\"ROBERTS, Andrew\";i:9;s:16:\"BUCCHERI, Simona\";i:10;s:16:\"D'ASARO, Matilde\";i:11;s:14:\"GEBBIA, Nicola\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-07-0199\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"7450\";s:8:\"\u0000*\u0000epage\";s:4:\"7457\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DIELI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Francesco\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"VERMIJLEN, David\";i:1;s:16:\"SALERNO, Alfredo\";i:2;s:15:\"EBERL, Matthias\";i:3;s:16:\"HAYDAY, Adrian C\";i:4;s:14:\"FULFARO, Fabio\";i:5;s:14:\"CACCAMO, Nadia\";i:6;s:18:\"MERAVIGLIA, Serena\";i:7;s:16:\"CICERO, Giuseppe\";i:8;s:15:\"ROBERTS, Andrew\";i:9;s:16:\"BUCCHERI, Simona\";i:10;s:16:\"D'ASARO, Matilde\";i:11;s:14:\"GEBBIA, Nicola\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Targeting human \u03b3\u03b4 t cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
